Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 1998, p. 1938-1941, Vol. 36, No. 7
Department of Microbiology, University of
Leeds, Leeds LS2 9JT, United Kingdom,1 and
Institute for Medical Microbiology and Hygiene, University
of Cologne, Cologne, Germany2
Received 3 February 1998/Returned for modification 12 March
1998/Accepted 7 April 1998
Acinetobacter spp. are important
nosocomial pathogens reported with increasing frequency in outbreaks of
cross-infection during the past 2 decades. The majority of such
outbreaks are caused by Acinetobacter
baumannii. To investigate whether desiccation tolerance
may be involved in the ability of certain strains of A. baumannii to cause hospital outbreaks, a blind study was
carried out with 39 epidemiologically well-characterized clinical
isolates of A. baumannii for which survival
times were determined under simulated hospital conditions. The survival
times on glass coverslips of 22 strains isolated from eight
well-defined hospital outbreaks in a German metropolitan area were
compared with the survival times of 17 sporadic strains not involved
in outbreaks but rather isolated from inpatients in the same
geographic area. All sporadic isolates have been shown by pulsed-field
gel electrophoresis to represent different strain types. There was no
statistically significant difference between the survival times of
sporadic strains of A. baumannii and outbreak
strains (27.2 versus 26.5 days, respectively; P Acinetobacter
spp. are ubiquitous gram-negative bacteria that can be isolated from
soil, water, human skin, and the environment. Incomplete
taxonomic nomenclature has long prevented a detailed investigation of
the epidemiology of the various genospecies that constitute the genus
Acinetobacter (14).
Currently, at least 19 genomic species are recognized as members of the
genus (3, 11). Acinetobacter
spp. may cause a wide range of opportunistic infections, principally in
elderly patients, infants, and patients with severe underlying disease.
Those in intensive care units (ICU) with assisted mechanical
ventilation and urinary or intravascular catheters are at particular
risk. In an international multicenter study of blood culture isolates,
Acinetobacter spp. were ranked among the
top ten bacteria causing septicemia in 18 of 44 large European
hospitals (31). It has been shown that most clinical isolates are strains of Acinetobacter
baumannii (23) and that this species together
with Acinetobacter DNA group 13TU is
involved in the majority of
Acinetobacter hospital outbreaks
(3), whereas species such as
Acinetobacter DNA group 3 and
Acinetobacter junii have only
occasionally been implicated in outbreaks of nosocomial infection
(4, 17). A. baumannii isolates are
resistant to many of the currently used antibiotics, and resulting
infections are often difficult to treat. Imipenem remains the most
active drug, but unfortunately the emergence of imipenem-resistant
strains has been documented in recent hospital outbreaks (5,
16).
Compared with other genera of gram-negative bacilli,
Acinetobacter is found to survive much
better on fingertips or on dry surfaces when tested under simulated
hospital environmental conditions (19, 20). The skin of
patients and medical personnel is thought to be involved in the
transmission of strains, and in some outbreaks, molecular typing has
identified the epidemic strain on the skin of patients (12, 13,
22). Allen and Green (1) were the first to report that
airborne spread may also serve as a mode of transmission. Contaminated
reusable medical equipment, such as ventilator tubing, respirometers,
and arterial pressure monitoring devices, used for the management of
severely ill patients has also been implicated as a route of
transmission to patients (2, 6, 8, 17). In addition, a wide
variety of dry environmental objects such as bed mattresses
(29), pillows (33), a tape recorder, a television
set, and a fan (18) have been found to be contaminated with
Acinetobacter and may serve as
reservoirs during nosocomial outbreaks.
Survival responses of different
Acinetobacter spp. have been studied to
some extent previously (15, 19, 34), but there are no
reports comparing the desiccation tolerances of sporadic and outbreak
strains of A. baumannii. To assess whether
desiccation tolerance is a characteristic feature of epidemic
A. baumannii, the survival times of 22 clinical
A. baumannii strains isolated from eight
hospital outbreaks were compared with those of 17 sporadic, non-outbreak-related strains. In addition, resistance to commonly used
broad-spectrum antimicrobials was also compared between the epidemic
and sporadic strains.
Bacterial strains.
Details of the strains used in this
investigation are given in Tables 1 and
2. Twenty-two of these strains were
isolated from eight well-defined hospital outbreaks in the Cologne
metropolitan area in Germany and represented eight different clonal
strains (two to four isolates from each outbreak). Details of these
outbreaks have been described elsewhere (24, 25). Seventeen
strains were sporadic isolates from hospitalized patients in the same geographic area but were epidemiologically unrelated and represented different strain types, as demonstrated previously by pulsed-field gel
electrophoresis. All of these strains have been identified to the
species level by current genotyping methods and have been well
characterized in previous studies (26). A. baumannii ATCC 19606T was also studied for
comparison. Strains were grown on Iso-Sensitest agar (Oxoid Unipath,
Hants, Basingstoke, United Kingdom) at 30°C. For long-term storage,
strains were kept in 15% (vol/vol) glycerol broth at
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Survival of Acinetobacter
baumannii on Dry Surfaces: Comparison of Outbreak and
Sporadic Isolates
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
0.44) by the Wilcoxon-Mann-Whitney test. All investigated A. baumannii strains, irrespective of their areas of
endemicity or epidemic occurrence, have the ability to survive for a
long time on dry surfaces. Antimicrobial susceptibility testing showed that A. baumannii outbreak strains were
significantly more resistant to various broad-spectrum antimicrobial
agents than sporadic strains. Both desiccation tolerance and multidrug
resistance may contribute to their maintenance in the hospital setting
and may explain in part their propensity to cause prolonged outbreaks
of nosocomial infection.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
70°C.
TABLE 1.
Survival times of sporadic strains of A. baumannii suspended in distilled water and kept at 31%
RH and at a room temperature of 22 ± 3°Ca
TABLE 2.
Survival times of outbreak strains of A. baumannii suspended in distilled water and kept at 31%
RH and at a room temperature of 22 ± 3°C
Desiccation survival assay. The procedure described by Jawad et al. (19) was followed to determine the length of time that strains could survive on glass coverslips when kept at 31% relative humidity (RH). A 1-ml aliquot of overnight nutrient broth culture was placed in a 1.5-ml Eppendorf tube and centrifuged for 5 min in a microcentrifuge (MSE Scientific Instruments, Crawley, Surrey, United Kingdom) at 11,600 × g. The supernatant fluid was discarded, and the cells were washed once with 1 ml of distilled water and then resuspended in another 1 ml. Twenty microliters of these suspensions (approximately 2 × 107 CFU) was deposited onto sterile 13-mm-diameter rounded glass coverslips, placed in uncovered petri dishes, and kept in airtight transparent plastic boxes (17 by 11 by 5.5 cm). The RH inside the plastic boxes was maintained at 31% ± 3% by the presence of a saturated salt solution of CaCl2 · 6H2O in an open 5-ml beaker. This RH was chosen as an approximation to conditions in United Kingdom hospitals. A digital thermohygrometer (Fison Scientific Equipment, Loughborough, Leicestershire, United Kingdom) was used to monitor RH and temperature.
Determination of viable counts.
Viable counts were
determined for the original nutrient broth cultures and the bacterial
cell suspensions prior to inoculation onto the glass coverslips.
Zero-time viable counts were determined by washing a glass coverslip in
2 ml of sterile distilled water, vortexing the fluid vigorously for
15 s, and inoculating 100-µl aliquots onto Iso-Sensitest agar
plates by the spread plate method, after appropriate dilutions in
distilled water had been made. The CFU appearing after overnight
incubation at 30°C in air were counted. Viable counts were determined
every 24 h and compared with the count of the original bacterial
cell suspension. Three glass coverslips were used separately for every
count, and three different dilutions were made for every coverslip.
When the viable count decreased to
30 CFU on an agar plate after
overnight incubation, an agar incorporation method was used to
determine the viable count (19). Each assay was repeated
three times, and the mean survival time was calculated.
Susceptibility testing. MICs were determined by a broth dilution method with factory-prepared antibiotic dilutions in microtiter trays (Micronaut-S; Merlin Diagnostics, Bornheim, Germany) in accordance with guidelines established by the National Committee for Clinical Laboratory Standards (NCCLS) (21). The following antimicrobials were included: gentamicin, amikacin, amoxicillin-clavulanate, mezlocillin, piperacillin-tazobactam, meropenem, imipenem, cefuroxime, cefepime, ceftriaxone, cefotaxime, and ciprofloxacin.
| |
RESULTS |
|---|
|
|
|---|
Survival time was defined as the length of time taken for the
viable counts to reach a value of zero on three consecutive days, as
determined by the agar incorporation assay, which was capable of
detecting
1 CFU/coverslip. The mean survival times of the
various A. baumannii isolates tested are shown
in Tables 1 and 2. The mean survival time for sporadic strains
was 27.29 days (range, 21 to 32 days), while the mean
survival time for outbreak strains was 26.55 days (range, 21 to 33 days). No statistically significant difference between the
survival times of outbreak and sporadic strains of A. baumannii (P
0.44) was found when the Wilcoxon-Mann-Whitney test of significance was applied. The mean survival time for A. baumannii ATCC
19606T was 6 days, which was significantly less time than
that of the 39 clinical isolates of A. baumannii (mean survival time, 27 days). None of the
strains exhibited mucoid colonies on the Iso-Sensitest agar. The mean
survival times of wound swab isolates, catheter isolates, urine
isolates, tracheal aspirate isolates, and blood isolates were 28, 27.4, 27, 26.8, and 26 days, respectively.
The in vitro activities of the various agents against sporadic and outbreak isolates of A. baumannii are shown in Table 3. All the strains tested were resistant to cefuroxime and sensitive to imipenem, meropenem, and piperacillin-tazobactam, with no difference between the geometric mean MICs for sporadic and outbreak isolates. A. baumannii outbreak strains, however, were significantly more resistant to aminoglycosides, amoxicillin-clavulanate, mezlocillin, cefepime, ceftriaxone, cefotaxime, and ciprofloxacin than sporadic isolates. This difference was most pronounced for gentamicin (geometric mean MICs, 12.1 and 5.0 mg/liter and percentages of isolates fully susceptible at NCCLS breakpoints, 25 and 67% for epidemic and sporadic isolates, respectively), amikacin (geometric mean MICs, 27.6 and 3.6 mg/liter and percentages of isolates fully susceptible, 63 and 100% for epidemic and sporadic isolates, respectively), and ciprofloxacin (geometric mean MICs, 10.6 and 1.3 mg/liter and percentages of isolates fully susceptible, 13 and 100% for epidemic and sporadic isolates, respectively).
|
| |
DISCUSSION |
|---|
|
|
|---|
There are reports of individual endemic strains of A. baumannii persisting in hospitals for up to 3 years
(13, 24, 29, 32). It is currently unknown why some strains
have a propensity for causing hospital outbreaks while others are only
sporadically recovered from colonized or infected patients. Resistance
to adverse environmental conditions such as desiccation is one
property that might enhance transmissibility and might be
characteristic of outbreak strains, distinguishing them from
non-outbreak-related strains. Burkholderia cepacia is
another gram-negative pathogen responsible for an increasing number of
nosocomial infections. Significant strain-to-strain differences in
survival on dry surfaces have been reported, and Drabick et al.
(10) have proposed that enhanced survival time may
contribute to the apparent increased transmissibility of some strains
of B. cepacia. A blind study was therefore carried out
to compare survival times of clinical strains of A. baumannii representing eight well-described hospital outbreaks in the Cologne metropolitan area in Germany with survival times of epidemiologically unrelated sporadic strains isolated in the
same geographic area. All isolates have been extensively characterized
by modern molecular typing techniques. The response to drying, as
measured by the survival time on glass coverslips, of A. baumannii strains was similar to that of
Staphylococcus aureus tested previously in the same
assay (19). The mean survival time of the German clinical
isolates was 27 days and was as long as 33 days for some isolates.
However, no statistically significant difference between the survival
times of outbreak strains versus those of sporadic strains was found,
suggesting that all strains may, when environmental conditions and
opportunity permit, cause multiple infections. These conditions may
include poor hygiene, improper disinfection measures, and probably the
high degree of selective pressure associated with the extensive use of
broad-spectrum antimicrobial agents. The last condition is supported by
our observation that A. baumannii strains
involved in hospital outbreaks are significantly more resistant to
commonly used broad-spectrum antibiotics such as aminoglycosides,
-lactams, and fluoroquinolones than strains isolated only
sporadically. This resistance may provide certain A. baumannii strains with a selective advantage in a setting
where there is extensive exposure to antimicrobials, such as the modern ICU. Similar findings were also reported by Dijkshoorn et al. (9), who found that epidemic A. baumannii strains were more resistant to gentamicin and
carbenicillin than sporadic isolates, without giving further details.
The previous observation that clinical A. baumannii strains are more resistant to desiccation than American Type Culture Collection A. baumannii strains (19, 34) was confirmed in the present study. There is currently no explanation for this finding, but it may be a consequence of the repeated subculturing that the type strain has undergone over the years. Greater variability in the ability to survive under dry conditions among different A. baumannii strains has been reported by Wendt et al. (34), who noted that strains isolated from dry sources survived better than those isolated from wet sources (34). However, this observation was based on a study of just six A. baumannii strains. Our findings, based on 25 distinct strains, including some recovered from urinary tract infections, do not support this observation.
It has been shown previously that A. baumannii strains survive desiccation far better than other Acinetobacter species such as A. johnsonii, A. junii, and A. lwoffii (19, 20). This may explain why strains belonging to these other species have only very rarely been implicated in hospital outbreaks (4, 17). Acinetobacter spp. form part of the bacterial flora of the skin of healthy subjects, patients, and hospital staff, particularly in moist regions such as axillae, the groin, and toe webs, and between 25 and 43% of healthy individuals carry Acinetobacter spp. on their skin (12, 28, 30). Strains of Acinetobacter calcoaceticus survived better on fingertips than strains of A. lwoffii (20). However, A. johnsonii, A. lwoffii, and Acinetobacter radioresistens predominate on human skin, whereas skin carriage of A. baumannii, the species of Acinetobacter involved in the majority of nosocomial outbreaks, is very rare (1.5%) (28). Conversely, during outbreaks in the ICU setting, epidemic A. baumannii strains may be recovered with high frequency from skin and rectal samples (7, 27). Prior skin carriage of A. baumannii is an unlikely source of nosocomial outbreaks; rather, skin colonization is a result of multiple exposures to endemic A. baumannii in the ICU setting. Once colonized at one site, a bedridden patient may easily contaminate himself at any other body site. Increasing skin colonization was detected 1 or 2 weeks after admission in colonized or infected patients, respectively (14).
The skin of both patients and medical staff, as well as dry inanimate objects in hospital wards contaminated with A. baumannii, is able to facilitate transmission of strains and may serve as unrecognized reservoirs in prolonged nosocomial outbreaks. Desiccation tolerance and multidrug resistance, as shown here, may contribute to the ability of A. baumannii to cause hospital outbreaks and may explain why certain strains are able to establish themselves in the hospital environment while others are isolated only sporadically. Strain-to-strain variation in resistance to disinfectants and the ability to use a wide range of carbon sources for nutrition may be important additional factors. Proper disinfection of dry surfaces and medical equipment in the hospital ward, strict adherence to hand disinfection protocols, and prudent use of antimicrobials are crucial for the prevention of nosocomial transmission. The presence of capsules and fimbriae and the production of enzymes which may damage the infected host cells have all been implicated in the virulence of Acinetobacter spp. (3). It is not known whether expression of any of the postulated virulence factors is enhanced under drying conditions. There is now a need for a detailed investigtion of the pathogenicity factors of these bacteria, focusing on a comparison of outbreak and sporadic strains.
| |
ACKNOWLEDGMENT |
|---|
We thank the Ministry of Education of the Government of Pakistan for funding this work.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, University of Leeds, Leeds LS2 9JT, United Kingdom. Phone: 44-113-2335594. Fax: 44-113-2335649. E-mail: j.heritage{at}leeds.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Allen, K. D., and H. T. Green. 1987. Hospital outbreak of multi-resistant Acinetobacter anitratus: an airborne mode of spread? J. Hosp. Infect. 9:110-119[Medline]. |
| 2. |
Beck-Sagué, C. M.,
W. R. Jarvis,
J. H. Brook,
D. H. Culver,
A. Potts,
E. Gay,
B. W. Shotts,
B. Hill,
R. L. Anderson, and M. P. Weinstein.
1990.
Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units.
Am. J. Epidemiol.
132:723-733 |
| 3. | Bergogne-Bérézin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165[Medline]. |
| 4. | Bernards, A. T., A. J. Beaufort, L. Dijkshoorn, and C. P. A. van Boven. 1997. Outbreak of septicemia in neonates caused by Acinetobacter junii investigated by amplified ribosomal DNA restriction analysis (ARDRA) and four typing methods. J. Hosp. Infect. 35:129-140[Medline]. |
| 5. | Brown, S., C. Bantar, H. Young, and S. Amyes. 1996. An outbreak of imipenem resistance in Acinetobacter strains from Buenos Aires, Argentina, abstr. C-122, p. 56. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. |
| 6. | Cefai, C., J. Richards, F. K. Gould, and P. McPeake. 1990. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J. Hosp. Infect. 15:177-182[Medline]. |
| 7. | Corbella, X., M. Pujol, J. Ayats, M. Sendra, C. Ardanuy, M. A. Dominguez, J. Linares, J. Ariza, and F. Gudiol. 1996. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin. Infect. Dis. 23:329-334[Medline]. |
| 8. |
Cunha, B. A.,
J. J. Klimek,
J. Gracewski,
J. C. McLaughlin, and R. A. Quintiliani.
1980.
A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers.
Postgrad. Med. J.
56:169-172 |
| 9. | Dijkshoorn, L., H. Aucken, P. Gerner-Smidt, P. Janssen, M. E. Kaufmann, J. Garaizar, J. Ursing, and T. L. Pitt. 1996. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J. Clin. Microbiol. 34:1519-1525[Abstract]. |
| 10. | Drabick, J. A., E. J. Gracely, G. J. Heidecker, and J. J. LiPuma. 1996. Survival of Burkholderia cepacia on dry environmental surfaces. J. Hosp. Infect. 32:267-277[Medline]. |
| 11. | Ehrenstein, B., A. T. Bernards, L. Dijkshoorn, P. Gerner-Smidt, K. J. Towner, P. J. M. Bouvet, F. D. Daschner, and H. Grundmann. 1996. Acinetobacter species identification by using tRNA spacer fingerprinting. J. Clin. Microbiol. 34:2414-2420[Abstract]. |
| 12. | French, G. L., M. W. Casewell, A. J. Roncoroni, S. Knight, and I. Phillips. 1980. A hospital outbreak of antibiotic-resistant Acinetobacter anitratus: epidemiology and control. J. Hosp. Infect. 1:125-131[Medline]. |
| 13. | Gerner-Smidt, P. 1987. Endemic occurrence of Acinetobacter calcoaceticus biovar anitratus in an intensive care unit. J. Hosp. Infect. 10:265-272[Medline]. |
| 14. | Gerner-Smidt, P. 1994. Acinetobacter: epidemiological and taxonomic aspects. APMIS 102:5-41. |
| 15. | Getchell-White, S. I., L. G. Donowitz, and D. H. M. Groeschel. 1989. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus. Infect. Control Hosp. Epidemiol. 10:402-407[Medline]. |
| 16. | Go, E. S., C. Urban, J. Burns, B. Kreiswirth, W. Eisner, N. Mariano, K. Mosinka-Snipas, and J. J. Rahal. 1994. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344:1329-1332[Medline]. |
| 17. | Horrevorts, A., K. Bergman, L. Kollée, I. Breuker, I. Tjernberg, and L. Dijkshoorn. 1995. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33:1567-1572[Abstract]. |
| 18. |
Jawad, A.,
P. M. Hawkey,
J. Heritage, and A. M. Snelling.
1994.
Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar.
J. Clin. Microbiol.
32:2353-2358 |
| 19. | Jawad, A., J. Heritage, A. M. Snelling, D. M. Gascoyne-Binzi, and P. M. Hawkey. 1996. Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces. J. Clin. Microbiol. 34:2881-2887[Abstract]. |
| 20. | Musa, E. K., N. Desai, and M. W. Casewell. 1990. The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica. J. Hosp. Infect. 15:219-227[Medline]. |
| 21. | National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4 National Committee for Clinical Laboratory Standards, Villanova, Pa. |
| 22. | Patterson, J. E., J. Vecchio, E. L. Pantelick, P. Farrel, D. Mazon, M. J. Zervos, and W. J. Heirholzer, Jr. 1991. Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am. J. Med. 91:479-483[Medline]. |
| 23. | Seifert, H., R. Baginski, A. Schulze, and G. Pulverer. 1993. The distribution of Acinetobacter species in clinical culture materials. Zentbl. Bakteriol. 279:544-552. |
| 24. | Seifert, H., B. Boullion, A. Schulze, and G. Pulverer. 1994. Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting. Infect. Control Hosp. Epidemiol. 15:520-528[Medline]. |
| 25. |
Seifert, H.,
A. Schulze,
R. Baginski, and G. Pulverer.
1994.
Comparison of four different methods in the epidemiologic typing of Acinetobacter baumannii.
J. Clin. Microbiol.
32:1816-1819 |
| 26. | Seifert, H., and P. Gerner-Smidt. 1995. Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J. Clin. Microbiol. 33:1402-1407[Abstract]. |
| 27. | Seifert, H., A. Schulze, R. Hofmann, and G. Pulverer. 1996. Skin and mucous membrane colonization is an important source of nosocomial Acinetobacter baumannii infection: a prospective surveillance study, abstr. 7. Presented at the International Congress for Infectious Diseases, Hong Kong, 1996 . |
| 28. | Seifert, H., L. Dijkshoorn, P. Gerner-Smidt, N. Pelzer, I. Tjernberg, and M. Vaneechoutte. 1997. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J. Clin. Microbiol. 35:2819-2825[Abstract]. |
| 29. | Sheretz, R. J., and M. L. Sullivan. 1985. An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients' mattresses. J. Infect. Dis. 151:252-258[Medline]. |
| 30. | Taplin, D., G. Rebell, and N. Zaias. 1963. The human skin as a source of Mima-Herellea infections. JAMA 186:952-955. |
| 31. | Washington, J. A., and the International Collaborative Blood Culture Study Group. 1992. An international multicenter study of blood culture practices. Eur. J. Clin. Microbiol. Infect. Dis. 11:1115-1128[Medline]. |
| 32. | Webster, C. A., K. J. Towner, G. L. Saunders, H. Crew-Brown, and H. Humphreys. 1997. Contrasting epidemiological relationships of Acinetobacter isolates from hospitals in the UK and South Africa, abstr. P876. Clin. Microbiol. Infect. 3(Suppl. 2):213. |
| 33. | Weernink, A., W. P. J. Severin, I. Tjernberg, and L. Dijkshoorn. 1995. Pillows, an unexpected source of Acinetobacter. J. Hosp. Infect. 29:189-199[Medline]. |
| 34. | Wendt, C., B. Dietz, K. Dietz, and H. Rueden. 1997. Survival of Acinetobacter baumannii on dry surfaces. J. Clin. Microbiol. 35:1394-1397[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»